Century Therapeutics, Inc.IPSCNASDAQ

Revenue (LTM)

$109M

+1556.8% YoY

Net Income (LTM)

$-10M

+92.4% YoY

Free Cash Flow

$-105M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	5	2↓57.0%	7↑194.8%	109↑1556.8%
Gross Profit	-5	5↑213.5%	2↓57.0%	7↑194.8%	96↑1357.9%
Operating Income	-95	-134↓41.0%	-147↓9.5%	-138↑5.7%	-15↑89.1%
Net Income	-96	-131↓36.6%	-137↓4.4%	-127↑7.4%	-10↑92.4%
EBITDA	-90	-121↓34.8%	-121↓0.0%	-111↑8.0%	-2↑98.3%
EPS Diluted	-1.74	-2.27↓30.5%	-2.30↓1.3%	-1.61↑30.0%	-0.11↑93.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	56	84↑49.3%	47↓43.8%	58↑23.5%	62↑5.8%
Total Current Assets	228	320↑40.1%	177↓44.6%	194↑9.6%	121↓37.8%
Total Assets	437	487↑11.2%	361↓25.9%	353↓2.1%	224↓36.7%
Total Current Liabilities	16	30↑90.5%	18↓40.1%	130↑627.2%	20↓84.4%
Total Liabilities	41	184↑346.8%	176↓4.3%	192↑9.0%	65↓66.2%
Total Equity	396	303↓23.6%	185↓39.0%	161↓12.7%	159↓1.5%
Total Debt	25	49↑96.7%	48↓2.5%	54↑11.7%	44↓19.1%
Net Debt	-31	-35↓11.2%	1↑102.4%	-5↓644.4%	-18↓296.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-89	14↑115.8%	-88↓728.7%	-110↓24.7%	-104↑5.7%
Capital Expenditure	-45	-31↑31.9%	-14↑55.1%	-0↑98.9%	-1↓450.6%
Free Cash Flow	-134	-17↑87.6%	-102↓516.7%	-110↓8.0%	-105↑5.0%
Stock-Based Comp	5	11↑128.9%	15↑37.1%	13↓13.2%	7↓46.1%
Net Change in Cash	30	28↓7.7%	-37↓231.5%	12↑132.2%	4↓68.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance